Literature DB >> 2239736

Safety and efficacy of in-office cardioversion for treatment of supraventricular arrhythmias.

M F Lesser1.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2239736     DOI： 10.1016/0002-9149(90)91117-o

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  4 in total

Review 1.  Pharmacological cardioversion of atrial fibrillation: current management and treatment options.

Authors:  Giuseppe Boriani; Igor Diemberger; Mauro Biffi; Cristian Martignani; Angelo Branzi
Journal:  Drugs       Date:  2004       Impact factor: 9.546

2.  A dedicated cardioversion unit for the treatment of atrial fibrillation. Reducing costs by optimizing processes.

Authors:  C Knackstedt; M Becker; K Mischke; R Pauling; H P Brunner-La Rocca; P Schauerte
Journal:  Herz       Date:  2011-11-19       Impact factor: 1.443

3.  Reduced motion external defibrillation: Reduced subject motion with equivalent defibrillation efficiency validated in swine.

Authors:  Ehud J Schmidt; Hassan Elahi; Eric S Meyer; Ryan Baumgaertner; Luca Neri; Ronald D Berger; Harikrishna Tandri; David W Hunter; Steven P Cohen; Matt T Oberdier; Henry R Halperin
Journal:  Heart Rhythm       Date:  2022-02-28       Impact factor: 6.779

Review 4.  Emergency management of atrial fibrillation.

Authors:  A Wakai; J O O'Neill
Journal:  Postgrad Med J       Date:  2003-06       Impact factor: 2.401
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.